The Central Question: Is the Coaching Bundle Worth the Premium?
Noom Med and Found represent a specific category of GLP-1 telehealth platform: medication bundled with behavioral coaching. Both charge more than medication-only platforms because they include coaching infrastructure — apps, health coaches, behavioral content, habit tracking — alongside the GLP-1 prescription. The question that determines which of these three providers is right for you is whether that coaching bundle adds enough clinical value to justify the premium you pay for it.
This is not a rhetorical question. Behavioral coaching alongside GLP-1 medication does have clinical support. Wadden et al. (JAMA, 2021) found that adding intensive behavioral therapy to semaglutide produced modestly greater weight loss than semaglutide with standard counseling. And long-term maintenance data consistently shows that patients who develop sustainable behavioral habits during GLP-1 treatment maintain weight better after medication is tapered. The coaching that Noom Med and Found provide addresses a real clinical need.
The practical question is whether you specifically will engage with the coaching consistently enough for it to change your outcomes — and whether the specific coaching each platform provides is worth its specific premium over medication-only alternatives. The clinical evidence suggests the medication is the primary driver (~15–21% weight loss from the drug itself), and coaching adds a modest increment — but that increment is only realized if you actually use the coaching.
Quick Snapshot: Three Platforms
Noom Med: CBT-Based Coaching Integrated With GLP-1
Noom Med is the prescription arm of Noom, the behavioral weight loss app that uses cognitive behavioral therapy (CBT) principles to change patients' relationship with food. Noom's core product was a non-prescription app; Noom Med extends it by adding GLP-1 medication prescribing to the same platform.
Noom's CBT-based coaching is genuinely differentiated from generic health coaching. The daily app lessons are grounded in psychological principles about habit formation, emotional eating, food categorization (the green/yellow/red system), and long-term behavioral change. For patients who specifically struggle with the psychological dimension of eating, Noom's CBT framework addresses the root behavioral architecture rather than just surface-level tracking.
The pricing structure is where complexity enters, and where marketing can be misleading. Noom advertises "GLP-1 plans starting at just $69/month" — but this is the base membership/telehealth fee and does not include medication. Noom offers a lower-dose "Microdose GLP-1Rx" plan at approximately $79/month, and a full-dose compounded semaglutide program at approximately $279/month (billed as $837 for a 12-week cycle, with no monthly payment option and limited mid-cycle cancellation flexibility). Noom does not offer compounded tirzepatide in any form. Verify current Noom Med pricing and billing structure directly at noom.com — the full cost is not always clearly disclosed until checkout.
Found: Weight-Loss-Focused Coaching with Tirzepatide Access
Found is a standalone weight management telehealth platform built specifically around GLP-1 prescribing. Unlike Noom, which adapted its behavioral coaching app to include medication, Found was purpose-built as a GLP-1 weight management service from the start. Their coaching is oriented toward the practical aspects of weight loss with medication — side effect management, habit building, accountability, and nutritional adjustments — rather than deep CBT-based psychological work.
Found's key advantage over Noom Med is tirzepatide access. Found offers compounded tirzepatide at approximately $199 to $249/month — making tirzepatide available to cash-pay patients, something Noom Med does not offer at all. Found's semaglutide starts at approximately $129 to $149/month at lower doses, though it escalates to $179 to $199/month at maintenance — a dose-tier increase that patients should understand before enrolling.
Found's coaching bundle (coaches, app tools, habit tracking, community) is included in the subscription price without the kind of separate billing structure Noom Med uses. The trade-off is that Found's coaching is more practically oriented and less psychologically deep than Noom's CBT approach. For patients whose primary goal is behavioral support during GLP-1 treatment rather than fundamental food psychology work, Found's lighter-touch coaching may be adequate at a lower and more predictable price point.
Coaching Model Comparison: CBT vs Practical Weight Loss Support
Noom Med — CBT Psychology Approach
- Daily CBT-based lessons on food psychology
- Green/yellow/red food classification system
- Daily calorie logging and meal tracking
- Emotional eating pattern identification
- Group coaching with other Noom users
- Best for: patients with food psychology challenges
Found — Weight-Loss-Focused Approach
- In-app messaging with health coaches
- Side effect management guidance
- Medication-integrated habit building
- Behavioral science content and tools
- Community features and peer support
- Best for: practical support during GLP-1 treatment
What Clinical Evidence Says About GLP-1 + Coaching
The Evidence Base for Coaching + GLP-1 — Honest Assessment
12-Month Cost Comparison
| Provider | Sema Monthly | Tirz Monthly | 12-Mo Sema Total | Coaching Included |
|---|---|---|---|---|
| Noom Med | $79/mo (microdose) – $279/mo (full-dose) | Not offered | ~$948–$3,348 | CBT / psychology |
| Found | ~$129–$199/mo (dose-tier) | ~$199–$249/mo | ~$1,548–$2,388 | Weight-loss focused |
| ★ Luma Health | $197/mo flat | $297/mo flat | $2,364 (flat) | Not included (free alternatives available) |
Noom Med's range spans from a low-dose $79/month microdose plan to a $279/month full-dose compounded semaglutide program — with no compounded tirzepatide option at all. Found's 12-month range ($1,548–$2,388) is lower than Luma Health at starting doses but converges at maintenance, and Found does offer tirzepatide. Luma Health's $2,364/year flat is fully predictable at every dose tier throughout the treatment course, for both semaglutide and tirzepatide.
Full Three-Way Feature Comparison
| Factor | Noom Med | Found | Luma Health |
|---|---|---|---|
| Sema price | $79–$279/mo | ~$129–$199/mo (dose-tier) | $197/mo flat |
| Tirz price | Not offered | ~$199–$249/mo | $297/mo flat |
| Coaching included | ✓ CBT-based psychology app | ✓ Weight-loss health coaches | Not included |
| Coaching model | CBT / food psychology | Practical weight loss | Clinical oversight only |
| Dose-tier price increases | N/A (fixed plan tiers) | Yes (starting vs maintenance) | None — flat always |
| Billing transparency | Full price not clear until checkout | Clearer upfront pricing | Fully transparent, $197/mo |
| Pharmacy named publicly | Not prominently | Not prominently | ✓ VialsRX, TX #35264 |
| Contract required | 12-week minimum, no monthly option | Varies | None — cancel anytime |
| 12-mo sema total | ~$948–$3,348 | ~$1,548–$2,388 | $2,364 flat |
| Insurance nav (brand) | Limited | Limited | Cash-pay focus |
Who Each Platform Is Right For
Choose Noom Med If...
- You specifically want CBT-based food psychology coaching — you've struggled with emotional eating, food relationships, or psychological patterns around eating that standard habit tracking doesn't address
- You used the Noom app before and found it genuinely helpful for changing your food relationship
- You only need semaglutide (not tirzepatide) and are comfortable with a 12-week billing cycle
- Budget is less critical than psychological coaching quality
Choose Found If...
- You want practical coaching support during GLP-1 treatment without the full CBT depth (or 12-week billing) of Noom Med
- Tirzepatide access is important and you want it from the same platform as your coaching
- Found's starting dose pricing (~$129/mo) is the best fit for your budget in the early titration phase
- You want clearer upfront pricing with less risk of checkout surprises
★ Choose Luma Health If...
- You are self-directed and will not consistently use coaching — you want medication and clinical oversight at the flattest, most predictable rate
- Pharmacy transparency matters — VialsRX (TX #35264) publicly named and verifiable before you enroll
- You want both sema and tirz available at flat rates from one platform — $197/mo sema, $297/mo tirz
- You plan to supplement with free behavioral tools (MyFitnessPal, r/semaglutide, etc.) and don't need a paid coaching bundle
One flat price. No 12-week billing cycles.
$197/mo, month-to-month.
Compounded semaglutide $197/month flat. VialsRX pharmacy (TX Board #35264). No contracts. Wasef Health, PC clinical oversight.
Start With Luma Health →Frequently Asked Questions
It depends on the dose. Noom Med offers a lower-dose "Microdose GLP-1Rx" plan at approximately $79/month and a full-dose compounded semaglutide program at approximately $279/month (billed as $837 for a 12-week cycle). Found's semaglutide starts at approximately $129 to $149/month at lower doses, rising to $179 to $199/month at maintenance — a 12-month range of approximately $1,548 to $2,388. Luma Health at $197/month flat sits between these ranges, with the advantage of no dose-tier increases, no 12-week billing lock-in, and full tirzepatide availability (which Noom Med does not offer at all).
Yes. Found offers compounded tirzepatide at approximately $199 to $249/month as part of its core program. Noom Med does not offer compounded tirzepatide in any form — its GLP-1 program is built around semaglutide only. Luma Health also offers compounded tirzepatide at $297/month flat across all dose tiers as a core program offering. For patients who specifically want tirzepatide, Found and Luma Health are the options; Noom Med is not.
Behavioral coaching alongside GLP-1 medication does produce modestly better outcomes than medication with standard clinical oversight — Wadden et al. (JAMA 2021) found approximately 2 additional percentage points of weight loss with intensive behavioral therapy on top of semaglutide. However, this benefit is only realized if patients consistently engage with the coaching — the increment is from actually doing the behavioral work, not from subscribing to the platform.
Regular Noom (Noom Weight) is a behavioral weight loss app (calorie tracking, CBT lessons, food logging) that costs approximately $17/month on an annual plan and does not include prescription medication. Noom Med adds GLP-1 prescribing on top of the same behavioral platform, with medication billed separately and priced by tier: approximately $79/month for a lower-dose "Microdose" plan or approximately $279/month for the full-dose compounded semaglutide program.
Yes — and the transition is straightforward. Complete Luma Health's online intake at start.mylumahealth.com while you still have 2 to 3 weeks of your current medication remaining. Inform your Wasef Health, PC provider of your current semaglutide dose — no titration restart is needed. Wait for VialsRX shipping confirmation before canceling your Noom Med or Found subscription. Note that Noom Med's 12-week billing cycle may affect the timing of a clean cancellation — check your current billing cycle before switching.
Several free tools provide meaningful behavioral support without a paid subscription: MyFitnessPal and Lose It (calorie and food tracking, free tier), r/semaglutide and r/Tirzepatide on Reddit (active patient communities with peer support), Cronometer (macro tracking), and free CBT workbooks available online for the psychological framework Noom commercializes. For patients who switch to Luma Health and want structured behavioral support, occasional sessions with a registered dietitian (billed only when used) may be more cost-effective than a monthly coaching subscription regardless of engagement.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed 33567185
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed 35658024
- Wadden TA, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight. JAMA. 2021;325(14):1403–1413. PubMed 33755729
- Aronne LJ, et al. Continued Treatment with Tirzepatide for Maintenance of Weight Reduction (SURMOUNT-4). JAMA. 2024;331(1):38–48. PubMed 38078870
- Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes (SELECT). N Engl J Med. 2023;389:2221–2232. PubMed 37952131
- U.S. Food and Drug Administration. Human Drug Compounding — Section 503A. FDA.gov
- Noom Health. Noom Med Official Program and Pricing. noom.com
- Found Health. Found Weight Loss Program. joinfound.com